Efficacy of Dulaglutide as a First Injectable Option for Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis.
Hiren PatelKashif MunirSindee SutherlandChrisanthi A KaranikasManige KonigPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2019)
Eli Lilly and Company.
Keyphrases